Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection

NCT01203345 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

2416

Enrollment

NETWORK

Sponsor class

Conditions

Infant, Newborn
Infant, Low Birth Weight
Infant, Small for Gestational Age
Infant, Premature
Sepsis

Interventions

DRUG: IVIG
DRUG: Placebo

Sponsor

NICHD Neonatal Research Network